2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Gene Editing, Profiling, Treatment Considerations, Combination Therapy, Drug Development, Biological Therapies, Antibody Therapy, Transplantation, Immunotherapy, Non-Biological Therapies, Chemotherapy, Pharmacology, Radiation Therapy, Biological Processes, Hematopoiesis, Immune Mechanism, Metabolism, Microbiome, Molecular Biology, Multi-Systemic Interactions, Diseases, Bone Marrow Failure Syndromes, Immunology, GVHD, Lymphoid Malignancies, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, Study Population, Animal Model
PAPER

2329 Acute graft-versus-host disease induces organ-partitioned erythroid stress programs across bone marrow, spleen and liver

Meng Zhang, Hengwei Wu, MD2, XinYi Lai3, Meihua Zhu4, Yunfei Liu5, Mengmeng Huang, PhD6, Xiangjun Zeng, MD7, Yanmin Zhao, MD8, Fang Ye9, He Huang, MD, PhD10
1 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
3 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
4 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
5 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
6 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
7 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
8 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
9 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
10 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China

Background: Acute graft-versus-host disease (aGVHD) is commonly defined by target-organ injury, yet impaired hematopoiesis and delayed immune reconstitution are major complications after allogeneic hematopoietic stem cell transplantation. GVHD can damage the bone marrow (BM) niche and suppress B lymphopoiesis, but how it reshapes erythroid differentiation across BM, spleen and liver remains poorly understood.

 

Methods: Conditioned BALB/c mice received C57BL/6 BM alone as transplantation controls or the same BM plus donor T cells to induce aGVHD. Flow cytometry and histopathology were performed on days 7, 14 and 21 after transplantation. At the established disease stage on day 14, we performed single-cell RNA sequencing of BM, spleen and liver and high-resolution spatial transcriptomics (Stereo-seq) of spleen and liver. Erythroid cells were integrated across the three tissues and analyzed using compositional, pathway-scoring, pseudotime and spatial approaches.

 

Results: CD3+ T cells increased in all three organs during aGVHD, and more than 90% of recovered T cells were donor derived. In BM, expansion of T-cell states coincided with contraction of B-cell states. Reduced Ighm, Ly6d, Vpreb3, Bach2 and Ebf1 programs and increased Ccl5, Ifitm1/6 and Tox expression indicated a shift from B lymphopoiesis toward donor T-cell-associated inflammation. Flow cytometry independently confirmed reduced BM B cells and increased T cells. In spleen, white-pulp organization and B-cell-rich regions were disrupted. The liver lacked overt histological injury but showed increased representation of hepatic stellate-cell states, induction of the acute-phase and stress genes Saa1/2/3 and Mt1/2, and reduction of hepatocyte metabolic and iron-regulatory programs, including Hamp and Cyp3a11.

 

Integrated analysis resolved six erythroid states: megakaryocyte–erythroid progenitors, early erythroblasts, proliferating erythroblasts, stress-associated erythroid cells, MT-high erythroblasts and mature erythrocytes. Compared with controls, aGVHD samples showed increased representation of stress-associated erythroid cells and MT-high erythroblasts, with relative contraction of mature erythrocytes and progenitor or proliferative states. These states were organ-partitioned: spleen contributed prominently to progenitor and early erythroblast states, liver was enriched in stress-associated and later-pseudotime states, and BM preferentially contributed early or intermediate and MT-high states.

 

Pseudotime analysis inferred two erythroid differentiation paths. Control cells were preferentially represented in terminal states along a conventional maturation-associated path, whereas aGVHD cells were redistributed toward late states along an alternative stress-associated path. The latter showed dynamic changes in erythroid differentiation and maturation scores together with cytokine-signaling and immune-receptor programs. Stress-associated erythroid cells in aGVHD upregulated Fth1, Gpx4 and Mgst3 and were enriched for oxidative phosphorylation, aerobic respiration and mitochondrial ATP synthesis, consistent with enhanced oxidative-metabolic, iron-handling and antioxidant adaptation. Reactive-oxygen-species biosynthesis and innate immune-response programs were reduced. In spleen, spatial transcriptomics showed increased representation of erythroid-progenitor-enriched regions within the disrupted red pulp adjacent to T-cell-rich inflammatory areas, associating erythroid remodeling with the local alloimmune microenvironment.

 

Conclusions: aGVHD was associated with coordinated hematopoietic remodeling across BM, spleen and liver rather than isolated BM suppression. BM B-lymphopoietic failure coincided with an altered erythroid response characterized by splenic progenitor enrichment, hepatic accumulation of stress-adapted erythroid states and oxidative-metabolic and iron-handling reprogramming. These findings define an organ-partitioned hematopoietic response to aGVHD and provide a framework for investigating cytopenias and incomplete immune recovery after allogeneic transplantation.

Meng Zhang: No relevant conflicts of interest to declare.